Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-10-16Clinical Trial Update: Wellbutrin XL Effects on SSRIs Induced Changes [Phase 4]
Phase 4 trial completed evaluating how Wellbutrin XL affects SSRI-induced changes in depression.
-
FDA approval · 2007-10-10FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved Lannett Company's supplemental application for fluoxetine hydrochloride, a generic version of fluoxetine.
-
CLINICAL_TRIALS trial_result · 2007-10-02Clinical Trial Update: Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression [Phase 3]
Phase 3 study evaluating indiplon or placebo with sertraline in insomnia co-occurring with depression was terminated.
-
FDA approval · 2007-09-28FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., resulting in an approved label update for this g…
-
CLINICAL_TRIALS trial_result · 2007-09-24Clinical Trial Update: Pivotal Trial (D02) of Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depression (TRD) [NA]
A pivotal trial evaluating vagus nerve stimulation for treatment-resistant depression has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-09-20FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2007-09-19Clinical Trial Update: An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache [Phase 4]
This is a Phase 4 open-label trial evaluating duloxetine for comorbid major depressive disorder and chronic primary headache. The study stat…
-
FDA approval · 2007-09-17FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved Amneal's supplemental ANDA for generic bupropion hydrochloride, enabling marketing of a generic formulation.
-
CLINICAL_TRIALS research · 2007-09-17Clinical Trial Update: CBT to Treat Depression in Renal Patients [NA]
This entry notes a clinical trial evaluating cognitive-behavioral therapy for depression in patients with end-stage renal disease, with the …
-
CLINICAL_TRIALS trial_result · 2007-08-24Clinical Trial Update: Abilify Therapy for Reducing Comorbid Substance Abuse [Phase 4]
Phase 4 trial evaluating aripiprazole (Abilify) for reducing comorbid substance use across multiple psychiatric disorders; the study has com…
-
FDA approval · 2007-08-22FDA Approved: MIRTAZAPINE — Original Application (Apotex Corp.)
FDA approved Apotex Corp.'s generic mirtazapine tablet under an original Abbreviated New Drug Application (ANDA077666).
-
CLINICAL_TRIALS trial_result · 2007-08-21Clinical Trial Update: A Randomized Clinical Trial for Depressed Mothers at Primary Care Level [NA]
A randomized clinical trial evaluating treatment for depressed mothers in primary care has completed.
-
CLINICAL_TRIALS trial_result · 2007-08-20Clinical Trial Update: Pennsylvania Adolescent Intervention Research Study (PAIRStudy) [Phase 2]
Phase 2 PAIRStudy, an adolescent depression intervention, has been terminated. The sponsor is the Pennsylvania Department of Health.
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: Antidepressant Effect of Theta-Burst rTMS [Phase 2]
A Phase 2 clinical trial evaluating the antidepressant effects of theta-burst repetitive transcranial magnetic stimulation in major depressi…
-
FDA label_change · 2007-08-02FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for WELLBUTRIN XL, resulting in changes to the product labeling.
-
FDA approval · 2007-08-02FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2007-08-02FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Tranylcypromine Sulfate from Actavis Pharma, Inc. (Tranylcypromine Sulfate).
-
FDA approval · 2007-08-02FDA Approved: PHENELZINE SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for phenelzine sulfate, an MAOI antidepressant, expanding regulatory approval for this product.
-
FDA approval · 2007-08-01FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The action pertai…
-
CLINICAL_TRIALS trial_result · 2007-07-31Clinical Trial Update: Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression [Phase 3]
Phase 3 study comparing duloxetine to escitalopram and placebo in patients with depression; the trial has completed.
-
FDA approval · 2007-07-30FDA Approved: EMSAM — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for EMSAM (selegiline) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Maintenance Study for Adolescent Depression [Phase 4]
The document reports the completion of a Phase 4 maintenance study in adolescents with depression and summarizes the trial results.
-
FDA approval · 2007-07-25FDA Approved: PAROXETINE — Original Application (NorthStar Rx LLC)
FDA approves NorthStar Rx LLC's original ANDA for paroxetine hydrochloride (generic paroxetine).
-
FDA approval · 2007-07-12FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for venlafaxine hydrochloride submitted by Teva Pharmaceuticals USA, Inc. The approval updates t…
-
FDA label_change · 2007-07-12FDA Approved: CITALOPRAM — Supplemental Application (Chartwell Governmental & Specialty RX, LLC.)
FDA approved a supplemental application for citalopram from Chartwell Governmental & Specialty RX, LLC, likely resulting in a labeling updat…